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Alkyl lysophospholipid (ALP) analogs have received much interest in recent years because of 
their cytotoxic effects on malignant cells in vitro and in vivo. Although the mechanism of 
action of ALPs still remains to be elucidated, these agents do not affect nuclear DNA and are 
not genotoxic. Their major target sites appear to be in the plasma membrane. 
Structure activity relationship studies on a variety of alkyllysophosphocholines showed that a 
long alkyl chain and a phosphocholine moiety represent the minimal stuctural requirements 
for antineoplastic activity of ALPs. Hexadecylphosphocholine HePC (Miltefosine) represents 
the first anticancer agent which was specifically formulated for the topical, palliative treat-
ment of skin metastases in patients with breast cancer. Its therapeutic potential in further indi-
cations, such as cutaneous forms of leishmaniasis and skin cancer is being clinically tested. 
In order to probe the structural and stereochemical requirements of amphipathic ether lipids 
for optimal cytotoxicity and/or immunomodulation we have synthesized a variety of analogs 
containing different head groups and lipid portions. The head group contains several substi-
tuted amines while the lipid portion encompasses long aliphatic or alkoxyethyl chains or suit-
ably substituted aryloxyethyl moieties. 
The cytotoxic activity of the new compounds was evaluated in vitro against a panel of six 
human tumor xenografts and in two biochemical, mechanism based, screens. In addition, 
data on the fungistatic and fungicidal activity, as well as the parasiticidal action against the 
amastigotes Leishmania donovani and Leishmania tropica, of the new alkyllysophospholipids, 
will be presented. 
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